InvestorsHub Logo
icon url

DTGoody

06/04/17 1:07 PM

#66950 RE: docprep #66947

I Agree, USRM should be Dollars given all the recent positive Data on Stem Cell Therapy and the Success of their use in treating Diseases. USRM is on the Cusp of getting FDA Approval. Any other Bio Stock would automatically be trading $3 - $5 Dollars per share. The only reason USRM is being treated this way is that its still considered a penny stock. This will not last for much longer in my opinion. Now is the opportunity of a lifetime with USRM!